Silverberg Bernstein Capital Management LLC Pharming Group N.V. Call Options Transaction History

Silverberg Bernstein Capital Management LLC

  • $109 Billion
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding PHAR

# of Institutions
5
Shares Held
66.9K
Call Options Held
0
Put Options Held
0
View Full List

About Pharming Group N.V.

PHAR Quotes by TradingView
  • Ticker PHAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,241,400
  • Market Cap $491M
  • Description
  • Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...
More about PHAR
Track This Portfolio

Track Silverberg Bernstein Capital Management LLC Portfolio

Follow Silverberg Bernstein Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverberg Bernstein Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverberg Bernstein Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email